MondoTwin launches
The AI-native twin of a pharmaceutical company, launched on 7 October 2026.
MondoTwin opened its doors on 7 October 2026 with the launch of www.mondotwin.com. The company was founded by Francesco Cavalli, researcher at the ETH Agentic Systems Lab, and is an ETH Start-up.
MondoTwin builds the AI-native twin of a pharmaceutical company, department by department. The first department is business development: agents read clinical and regulatory evidence, identify licensing and development opportunities, and connect every assessment to its primary source. For pharmaceutical companies, MondoTwin is a business development department that finds the asset, constructs it in the client's name and stays with the client to signature. For researchers and their institutions, it is a platform on which they advance their own work and reach the companies able to develop it.
Dr Robert Jakob, founder and co-director of the Agentic Systems Lab, wrote on LinkedIn: "The ambition is to bring evidence-grounded agentic systems into the workflows of pharmaceutical organizations. The AI-native pharma company starts here."
